BPG is committed to discovery and dissemination of knowledge
Featured Articles
7/13/2023 10:36:01 AM | Browse: 358 | Download: 1283
Publication Name World Journal of Diabetes
Manuscript ID 83936
Country Italy
Received
2023-02-16 09:27
Peer-Review Started
2023-02-16 09:29
First Decision by Editorial Office Director
2023-04-11 06:39
Return for Revision
2023-04-11 06:39
Revised
2023-05-12 08:59
Publication Fee Transferred
Second Decision by Editor
2023-05-22 03:16
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2023-05-22 09:20
Articles in Press
2023-05-22 09:20
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-07-05 11:58
Publish the Manuscript Online
2023-07-13 08:03
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Ophthalmology
Manuscript Type Review
Article Title Klotho: A new therapeutic target in diabetic retinopathy?
Manuscript Source Invited Manuscript
All Author List Alessandra Puddu and Davide Carlo Maggi
Funding Agency and Grant Number
Corresponding Author Alessandra Puddu, BSc, Technician, Department of Internal Medicine and Medical Specialties, University of Genova, Viale Benedetto XV 6, Genova 16132, Italy. alep100@hotmail.com
Key Words Klotho; Diabetic retinopathy; Retinal pigment epithelium; Vascular endothelial growth factor A; Epithelial to mesenchimal transition; Ocular neovascularization
Core Tip In diabetic Patients, serum levels of Klotho (Kl) are significantly decreased compared to healthy subjects. Moreover, serum Kl levels are negatively correlated with worsening of diabetic retinopathy (DR). Several evidence suggests that retina homeostasis may be affected by altered expression of membrane Kl, as well by reduced levels of soluble Kl. In this review we focused on the role of Kl in DR, highlighting the importance of Kl in maintaining retinal homeostasis and its positive effects on several mechanisms involved in DR onset and progression. Therefore, Kl could be a novel biomarker and a good candidate for the treatment of DR.
Publish Date 2023-07-13 08:03
Citation Puddu A, Maggi DC. Klotho: A new therapeutic target in diabetic retinopathy? World J Diabetes 2023; 14(7): 1027-1036
URL https://www.wjgnet.com/1948-9358/full/v14/i7/1027.htm
DOI https://dx.doi.org/10.4239/wjd.v14.i7.1027
Full Article (PDF) WJD-14-1027-with-cover.pdf
Full Article (Word) WJD-14-1027.docx